Diabetologia

Article	Citations
Up Front	756
In Memoriam Werner Waldhäusl, 27 September 1937–22 May 2025	493
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo	222
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]	206
60th EASD Annual Meeting of the European Association for the Study of Diabetes	205
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection	185
Methodological considerations for interpreting long-term statin use and diabetes incidence	142
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification	133
Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study	129
Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative	127
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq	127
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities	110
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk	100
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study	100
58th EASD Annual Meeting of the European Association for the Study of Diabetes	99
Ageing well with diabetes: the role of technology	97
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study	95
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]	93
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin	90
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes	90
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory	90
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people	90
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes	85
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study	82
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care	81

Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation	80
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes	79
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)	75
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes	75
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials	73
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy	73
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study	72
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells	72
Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy	71
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap	70
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial	70
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes	70
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk	69
The role of automated insulin delivery technology in diabetes	68
Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry	66
Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data	64
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations	63
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study	63
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial	63
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open	62
Up Front	61
Daniel Porte Jr, 13 August 1931–13 May 2023	56
Mortality risk for kidney transplant candidates with diabetes: a population cohort study	55
Pinpointing precision medicine for diabetes mellitus	55
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals	54
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women	54
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis	52
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications	52
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy	51
Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity	51
Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome	50
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes	49
Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China	48
Bo Hellman, 19 June 1930–4 December 2023	48
Perspectives on human adipose tissue: from cellular mechanisms to clinical complications	48
Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes	47
Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study	47
Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover	46
Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women	45
Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men	45
Distinct subcellular localisation of intramyocellular lipids and reduced PKCε/PKCθ activity preserve muscle insulin sensitivity in exercise-trained mice	45
Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes	45
tRNA-derived fragments in T lymphocyte–beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice	45
Identification and interpretation of risk factors for Charcot foot	45
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes	45
Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes	44
Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells	44
Technology in the management of diabetes in hospitalised adults	44
(Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study	44
MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial	44

Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets	43
Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort	42
Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders	42
Comparative physiology and biomimetics in metabolic and environmental health: what can we learn from extreme animal phenotypes?	41
Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review	40
Declining FXR expression coordinates neonatal beta cell mass development with microbial bile acid metabolism maturation in mice	40
Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function	39
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial	39
Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry	39
High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment	39
Up Front	38
Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia	38
The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes	37
ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes	36
Genetics of diabetes-associated microvascular complications	36
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International	35
Editorial Expression of Concern: Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial	35
The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes	35
Women in diabetes research: we can do better. Reply to Bonnefond A [letter]	35
The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations	35
Up Front	35
Associations between parental type 2 diabetes risk and offspring birthweight and placental weight: a survival analysis using the Walker cohort	35
Feasibility and performance of minimal-volume capillary blood screening for type 1 diabetes and coeliac disease autoantibodies across all age groups: the UNISCREEN population study	34
Umbilical cord blood DNA methylation in children who later develop type 1 diabetes	34
Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study	32
Referees 2025	32
Transgender healthcare: metabolic outcomes and cardiovascular risk	32
Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter	31
Up Front	31
Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults	31
Incretins: turning the venom into the antidote	31
Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial	31
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology	31
Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study	31
Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity	31
Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial	31
Genetic variation in the RETN promoter, accompanied by latent sarcopenic obesity, led to insulin resistance in a Japanese cohort: the Toon Genome Study	31
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy	31
Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response	30
Pancreatic exocrine damage induces beta cell stress in zebrafish larvae	30
Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts	30
Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study	30
Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C	30
Disparities in access to and use of diabetes technologies and therapeutics: a narrative review	29
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis	29
Accuracy of continuous glucose monitoring in the hospital setting: an observational study	29
GlucoseGo: a simple tool to predict hypoglycaemia during exercise in type 1 diabetes	29
Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation	29
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach	29
Mitochondrial cristae density is increased following high-intensity interval training in men with type 2 diabetes	29
The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population	29
Short-term modulation of human milk oligosaccharides in plasma and milk by glucose and insulin: insights into postpartum metabolic regulation	29
Precision prognostics for the development of complications in diabetes	29
Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort	29
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease	28
BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells	28
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sánchez‑Hernández and Wägner [letter]	28
Ethnic differences in beta cell function and pancreatic fat in Black African and White European men across a spectrum of glucose tolerance	28
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter]	28
The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis	28
Correction to: Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China	28
RFX3 is essential for the generation of functional human pancreatic islets from stem cells	27
Apolipoprotein L genes are novel mediators of inflammation in beta cells	27
Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years	27
Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes	27
Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes	26
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app	26
Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational re	26
The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes	26
Precision nutrition in diabetes: when population-based dietary advice gets personal	26
Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis	26
Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial	26
Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications	26
Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans	25
The glycaemic response to morning fasted resistance exercise is more consistent than the response to afternoon fed resistance exercise for adults with type 1 diabetes: a randomised crossover compariso	25
Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes	25
METRNL represses beta-to-alpha cell trans-differentiation to maintain beta cell function under diabetic metabolic stress in mice	25
Thromboxane signalling links immune activation to enhanced glucose uptake in skeletal muscle	25
Metabolomic and genetic architecture of gestational diabetes subtypes	25
Childhood adiposity and novel subtypes of adult-onset diabetes: a Mendelian randomisation and genome-wide genetic correlation study	25

The genetics of low and high birthweight and their relationship with cardiometabolic disease	25
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing	24
Women in diabetes research: we can do better	24
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children	24
Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementat	24
Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter]	23
Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4	23
Referees 2024	23
TMEM55A-mediated PI5P signalling regulates alpha cell actin depolymerisation and glucagon secretion	23
Up Front	23
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage	23
Identification of SEC16B as a novel regulator of glucose homeostasis	23
Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications	23
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research	23
Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study. Reply to Liu W, Deng B [letter]	23
Diabetes and natural and man-made disasters: prevention, preparation, response and recovery	22
Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials	22
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk. Reply to Choi W [Letter]	22
Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases	22
GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes	21
Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank	21
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits	21
Correction: Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults	21
Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants	21
Technology advances in diabetes pregnancy: right technology, right person, right time	21
Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation	21
Heterogeneity of glycaemic phenotypes in type 1 diabetes	21
Health economic evaluation of a risk-stratified intervention in diabetic kidney disease	21
Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial	21
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers	21
Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse models	21
Effect of lipotoxic hepatocyte-derived extracellular vesicles in pancreas inflammation: essential role of macrophage TLR4 in beta cell functionality	21
Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes	21
Sex differences in body composition in people with prediabetes and type 2 diabetes as compared with people with normal glucose metabolism: the Maastricht Study	21
Effectiveness and safety of empagliflozin: final results from the EMPRISE study	21
Up Front	21
European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines	21
Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia	20
A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular–kidney complications	20
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review	20
Spatial proteomics of human diabetic kidney disease, from health to class III	20
Differential healthcare costs in individuals with type 2 diabetes and incident chronic kidney disease in Hong Kong: a latent class trajectory analysis	20
Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice	20
Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK	20
Up Front	20
Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors	20
Oral glucose absorption is enhanced in early metabolic dysfunction-associated steatotic liver disease	20
Methodological considerations for interpreting long-term statin use and diabetes incidence. Reply to Ma C, Zeng H [letter]	20
The moral equivalent: 60 years of publishing a scientific journal	20
Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes	20
Up Front	20
Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis	20
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial	19
Sex differences in type 2 diabetes	19
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question	19
Gut microbiota mediate melatonin signalling in association with type 2 diabetes	19
Sarah A. Hills RGN MSc, 28 September 1960–1 May 2023	19
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis	19
Up Front	18
Recurrent hypoglycaemia promotes cardiomyopathy and cardiac vulnerability in a rodent model of type 1 diabetes	18
Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease	18
Beyond BMI: the need for improved adiposity assessment in studying subclinical cardiovascular autonomic neuropathy in children with type 1 diabetes. Reply to Risi R, Buzzetti R, Maddaloni E [letter]	18
Morning exercise as fasted-state activity. Reply to Chacko E [letter]	18
Up Front	18
Lifetime history of gestational diabetes and cognitive function in parous women in midlife	18
Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study	18
Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis	18
Up Front	18
Pathophysiology of type 2 diabetes in sub-Saharan Africans	18
Persistent C-peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetes	18
John S. Yudkin, 25 June 1943–17 December 2025	18
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?	18
Compositional analysis of the association between 24 h movement behaviours, HbA1c and interstitial glucose in children and adolescents with type 1 diabetes mellitus: a two-year longitudinal analysis o	17
Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA	17
Correction: Effect of acute exercise and exercise training on the ability of insulin to clear branched‑chain amino acids from plasma in obesity and type 2 diabetes	17
Up Front	17
3D electron microscopy reveals novel ultrastructural changes in the diabetic retinal neurovascular unit	17
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset	17
Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults	17
What else can we do to prevent diabetic retinopathy?	17
Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes	17
The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum	17
Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes	17
Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression	17
Phenotypic and genetic classification of diabetes	17
Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank	17
Up Front	17
An unwelcome inheritance: childhood obesity after diabetes in pregnancy	17
A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome	17
The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice	16
The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomi	16
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a rando	16
Stephen Ashcroft, 27 January 1942–28 November 2025	16
Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis	16
Applying technologies to simplify strategies for exercise in type 1 diabetes	16